246 related articles for article (PubMed ID: 19028345)
1. Balancing risk and reward in target delineation for highly conformal radiotherapy in head and neck cancer.
Eisbruch A; Gregoire V
Semin Radiat Oncol; 2009 Jan; 19(1):43-52. PubMed ID: 19028345
[TBL] [Abstract][Full Text] [Related]
2. Patterns of failure after intensity-modulated radiotherapy in head and neck squamous cell carcinoma using compartmental clinical target volume delineation.
Bayman E; Prestwich RJ; Speight R; Aspin L; Garratt L; Wilson S; Dyker KE; Sen M
Clin Oncol (R Coll Radiol); 2014 Oct; 26(10):636-42. PubMed ID: 24928558
[TBL] [Abstract][Full Text] [Related]
3. Guidelines for delineation of lymphatic clinical target volumes for high conformal radiotherapy: head and neck region.
Vorwerk H; Hess CF
Radiat Oncol; 2011 Aug; 6():97. PubMed ID: 21854585
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
5. [Selection and delineation of lymph node target volumes in head and neck neoplasms].
Grégoire V; Daisne JF; Bauvois C; Coche E; Duprez T; Hamoir M; Reychler H
Cancer Radiother; 2001 Oct; 5(5):614-28. PubMed ID: 11715313
[TBL] [Abstract][Full Text] [Related]
6. Tumour shrinkage and contour change during radiotherapy increase the dose to organs at risk but not the target volumes for head and neck cancer patients treated on the TomoTherapy HiArt™ system.
Loo H; Fairfoul J; Chakrabarti A; Dean JC; Benson RJ; Jefferies SJ; Burnet NG
Clin Oncol (R Coll Radiol); 2011 Feb; 23(1):40-7. PubMed ID: 20926268
[TBL] [Abstract][Full Text] [Related]
7. Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy. Proposal for standardizing terminology and procedure based on the surgical experience.
Grégoire V; Coche E; Cosnard G; Hamoir M; Reychler H
Radiother Oncol; 2000 Aug; 56(2):135-50. PubMed ID: 10927132
[TBL] [Abstract][Full Text] [Related]
8. Positron emission tomography for radiation treatment planning.
Grosu AL; Piert M; Weber WA; Jeremic B; Picchio M; Schratzenstaller U; Zimmermann FB; Schwaiger M; Molls M
Strahlenther Onkol; 2005 Aug; 181(8):483-99. PubMed ID: 16044216
[TBL] [Abstract][Full Text] [Related]
9. Methods for estimating the site of origin of locoregional recurrence in head and neck squamous cell carcinoma.
Due AK; Vogelius IR; Aznar MC; Bentzen SM; Berthelsen AK; Korreman SS; Kristensen CA; Specht L
Strahlenther Onkol; 2012 Aug; 188(8):671-6. PubMed ID: 22580623
[TBL] [Abstract][Full Text] [Related]
10. Selection and delineation of target volumes in head and neck tumors: beyond ICRU definition.
Grégoire V; Daisne JF; Geets X; Levendag P
Rays; 2003; 28(3):217-24. PubMed ID: 15018310
[TBL] [Abstract][Full Text] [Related]
11. Hyperfractionated accelerated radiotherapy with concomitant integrated boost of 70-75 Gy in 5 weeks for advanced head and neck cancer. A phase I dose escalation study.
Cvek J; Kubes J; Skacelikova E; Otahal B; Kominek P; Halamka M; Feltl D
Strahlenther Onkol; 2012 Aug; 188(8):666-70. PubMed ID: 22648405
[TBL] [Abstract][Full Text] [Related]
12. Impact of the type of imaging modality on target volumes delineation and dose distribution in pharyngo-laryngeal squamous cell carcinoma: comparison between pre- and per-treatment studies.
Geets X; Daisne JF; Tomsej M; Duprez T; Lonneux M; Grégoire V
Radiother Oncol; 2006 Mar; 78(3):291-7. PubMed ID: 16499982
[TBL] [Abstract][Full Text] [Related]
13. Intensity-modulated radiation therapy for head and neck cancer: emphasis on the selection and delineation of the targets.
Eisbruch A; Foote RL; O'Sullivan B; Beitler JJ; Vikram B
Semin Radiat Oncol; 2002 Jul; 12(3):238-49. PubMed ID: 12118389
[TBL] [Abstract][Full Text] [Related]
14. On the delineation of the gross tumor volume and clinical target volume for head and neck squamous cell carcinomas.
Sanguineti G; Foppiano F; Marcenaro M; Roncallo F; Corvò R; Ameli F; Vitale V
Tumori; 2001; 87(3):153-61. PubMed ID: 11504370
[TBL] [Abstract][Full Text] [Related]
15. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing.
Eisbruch A; Marsh LH; Dawson LA; Bradford CR; Teknos TN; Chepeha DB; Worden FP; Urba S; Lin A; Schipper MJ; Wolf GT
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):28-42. PubMed ID: 15093896
[TBL] [Abstract][Full Text] [Related]
16. Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer.
Dawson LA; Anzai Y; Marsh L; Martel MK; Paulino A; Ship JA; Eisbruch A
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(5):1117-26. PubMed ID: 10725621
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive irradiation of head and neck cancer using conformal multisegmental fields: assessment of target coverage and noninvolved tissue sparing.
Eisbruch A; Marsh LH; Martel MK; Ship JA; Ten Haken R; Pu AT; Fraass BA; Lichter AS
Int J Radiat Oncol Biol Phys; 1998 Jun; 41(3):559-68. PubMed ID: 9635702
[TBL] [Abstract][Full Text] [Related]
18. Tools for optimal tissue sparing in concomitant chemoradiation of advanced head and neck cancer: subcutaneous amifostine and computed tomography-based target delineation.
Braaksma M; Levendag P
Semin Oncol; 2002 Dec; 29(6 Suppl 19):63-70. PubMed ID: 12577248
[TBL] [Abstract][Full Text] [Related]
19. Defining the target for radiotherapy of head and neck cancer.
Nuyts S
Cancer Imaging; 2007 Oct; 7 Spec No A(Special issue A):S50-5. PubMed ID: 17921086
[TBL] [Abstract][Full Text] [Related]
20. [Target-volume selection and delineation in the cervico-maxillo-facial region: beyond the concepts of the ICRU].
Grégoire V
Cancer Radiother; 2002 Nov; 6 Suppl 1():29s-31s. PubMed ID: 12587380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
